Dear OncoLink "Ask the Experts,"
I am currently being treated with oxaliplatin for metastatic colon cancer in the liver. Where do you think the most promising future colon cancer help will come from angiogenesis inhibitors, monoclonal antibodies, or vaccines?
James P. Stevenson, MD, Assistant Professor of Medicine in the Hematology/Oncology Division of the University of Pennsylvania School of Medicine, responds:
All of those agents (angiogenesis inhibitors, monoclonal antibodies, and vaccines) hold promise for colorectal cancer. At this point, no one agent seems to stand out. Examples of each that are being studied in colon cancer include;
Dec 8, 2010 - Daily aspirin over at least five years appears to greatly reduce mortality from gastrointestinal and non-gastrointestinal cancers, according to research published online Dec. 7 in The Lancet.
Dec 8, 2010
Jun 16, 2010